Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical ...
The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional randomized controlled trials (RCTs), computational modeling and simulation (CM&S ...
A study by the British Journal of Clinical Pharmacology (BJCP) has shown that by using artificial intelligence (AI), clinical trial assessors have been able to more than halve the time it takes to ...